Skip to main content
. 2021 Nov 1;21:266. doi: 10.1186/s12871-021-01480-w

Table 3.

Level of experience with bronchial blockers

Northern Europe n = 55 Eastern Europe n = 57 Southern Europe n = 105 Western Europe n = 257 Total n = 474
No experience 32.7% 49.1% 24.8% 19.5% 25.7%
Infrequent use, supervision required 20.0% 19.3% 20.0% 23.3% 21.7%
Occasional use, no supervision required 30.9% 15.8% 26.7% 29.2% 27.2%
Regular use 10.9% 7.0% 16.2% 14.4% 13.5%
expert 5.5% 8.8% 12.4% 13.6% 11.9%